Monsenso A/S (CPH:MONSO)
Denmark · Delayed Price · Currency is DKK 0.2500
+0.0400 (19.05%)
Oct 16, 2026, 9:00 AM CET
Monsenso Market Cap
Monsenso has a market cap or net worth of 23.98 million as of October 15, 2026. It is the 46,768th most valuable company in the world and the 133rd biggest in Denmark. Its market cap has increased by 79.54% in one year.
Market Cap
23.98M
Enterprise Value
24.78M
Revenue
7.07M
Global Rank
Country Rank
#133 Denmark
PE Ratio
n/a
ChartMarket Cap Chart
Since June 10, 2020, Monsenso's market cap has decreased from 96.87M to 23.98M, a decrease of -75.25%. That is a compound annual growth rate of -19.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 23.98M | 139.38% |
| Dec 30, 2025 | 10.02M | -59.16% |
| Dec 30, 2024 | 24.52M | 177.63% |
| Dec 29, 2023 | 8.83M | -21.75% |
| Dec 30, 2022 | 11.29M | -59.30% |
| Dec 30, 2021 | 27.73M | -82.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.13T |
| Genmab | 148.25B |
| Coloplast | 102.52B |
| Demant | 74.83B |
| Gubra | 4.77B |
| BioPorto | 507.49M |
| Pharma Equity Group | 97.22M |
| ViroGates | 71.01M |